Loss of in vivo tumorigenic potential of SNU-478 cells after AGR2 knockdown suggests that AGR2 expression is required to establish and to maintain stable tumor xenograft of the biliary tract cancer cells. The gene discussed is AGR2; the disease is neoplasm.